𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adjuvant Immunotherapy for patients with melanoma

✍ Scribed by Jeffrey N. Myers

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
29 KB
Volume
20
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adjuvant immunotherapy for patients with
Adjuvant immunotherapy for patients with melanoma: Are patients with melanoma of the head and neck candidates for this therapy?
✍ Palma M. Shaw; Muthukumaran Sivanandham; Stephanie F. Bernik; Kristen Ditaranto; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 2 views

Background. Although a wealth of information is available on adjuvant immunotherapy for melanoma, little is known about adjuvant immunotherapy for head and neck melanoma. Interestingly, a few immunotherapy clinical trials report the observation of clinical responses in a subset of patients with head

Overview of melanoma vaccines: Active sp
Overview of melanoma vaccines: Active specific immunotherapy for melanoma patients
✍ David W. Ollila; Mark C. Kelley; Guy Gammon; Donald L. Morton πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 2 views

Although a phase III trial has yet to show a statistically significant improvement in the disease-free or overall survival of melanoma patients receiving vaccine therapy, several phase II trials have shown enhanced disease-free and overall survival of patients who develop a humoral and/or cellular r

Active specific immunotherapy with polyv
Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastases
✍ Eddy C. Hsueh; Larry Nathanson; Leland J. Foshag; Richard Essner; J. Anne Nizze; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 341 KB πŸ‘ 2 views

## BACKGROUND. This study was conducted to document the rate, duration, and type of objective response to active specific immunotherapy with a polyvalent melanoma cell vaccine (PMCV) for patients with in-transit melanoma metastases and to identify any acute or chronic toxic effects of PMCV treatme